A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer - Wikidata - awgldk - TriplyDB

A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

http://www.wikidata.org/entity/Q34344182

about

Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis Distinct metabolic responses of an ovarian cancer stem cell line.A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial.Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6.Latest developments and emerging treatment options in the management of stomach cancer.A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.

P2860

Q34672942-13CD6499-4A82-4163-878B-3BEF0581BC83 Q35019030-29F713C8-B973-4609-A7BD-78DC6BF60D69 Q37205013-462516A7-F0BD-4E3F-8CAB-9DF2C1891355 Q37652629-6FA60F76-112D-48E8-8E69-A320B60543AD Q41898734-0FC4E297-E00B-439F-8903-96243CFC3E60 Q46396714-12FB1DA1-35F7-40EA-81CB-12E4FF5350C6 Q51028375-CA9A1142-E90A-4A56-BE33-E902A4D7AEE0

P2860

A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

http://www.wikidata.org/entity/Q34344182

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A phase II study of weekly doc ...... d or metastatic gastric cancer

@ast

A phase II study of weekly doc ...... d or metastatic gastric cancer

@en

A phase II study of weekly doc ...... d or metastatic gastric cancer

@nl

type

label

A phase II study of weekly doc ...... d or metastatic gastric cancer

@ast

A phase II study of weekly doc ...... d or metastatic gastric cancer

@en

A phase II study of weekly doc ...... d or metastatic gastric cancer

@nl

prefLabel

A phase II study of weekly doc ...... d or metastatic gastric cancer

@ast

A phase II study of weekly doc ...... d or metastatic gastric cancer

@en

A phase II study of weekly doc ...... d or metastatic gastric cancer

@nl

P1433

Q34344182-4A687737-F6EC-4E2F-90DC-498A0BFE7A13

P1476

Q34344182-B2FAF316-0C65-4ED7-B5A6-0FCFD49B7317

P2093

Q34344182-0F533F60-3B66-49A7-A797-076E8C09B606

Q34344182-3BAA7AD2-345A-4E7F-9E4C-92279C93C8DE

Q34344182-5974C257-46A1-454D-8A97-7CC092FCC3E1

Q34344182-60114A6F-B95A-49F9-8702-695A62625E02

Q34344182-6CFE4DA4-3163-49AE-B374-89C50D8217EF

Q34344182-AFF1173B-C52C-4CFD-8B32-C48D5C818BED

Q34344182-B8970042-416C-4B10-A7D0-563F85F4AC8A

Q34344182-C6766474-EB44-40F7-83A3-4D24C4AAB2C8

Q34344182-CCDB7D5E-C0E3-4802-9D68-BDD346186B79

Q34344182-F587A7B0-74D6-4498-AB3C-C5A0F6AC7E80

P2860

Q34344182-0F74445F-2604-435D-AF45-301849426F5F

Q34344182-2092A93A-5BA4-49F6-8122-9CCACBDF5099

Q34344182-2170AF79-B8D6-4B36-B087-E5ACFAAAAC8A

Q34344182-265CAF7D-9F9A-4846-9B78-9D4CE138887B

Q34344182-3417484F-4E4B-428E-A258-7BBF0B011EEC

Q34344182-3EB2ACB4-EFCF-4193-BF2E-52CEC475D3F2

Q34344182-44283683-0628-46AF-BF9C-86FD359E26E7

Q34344182-4B53F81B-FB18-477B-8C5F-3B25F11E2F15

Q34344182-4F9C357D-643A-40A6-83B2-0A3FE235E558

Q34344182-65C613CF-39FA-4A2E-AA25-24F0307E4B87

P2888

Q34344182-888E6AA0-A3B4-4BD9-8E73-DBAA9915B731

P304

Q34344182-7E91A912-766F-4BEA-AB4D-9D70E64CE11A

P31

Q34344182-E6DBF8D0-2AD9-474C-82AF-822CBD2D84BD

P356

Q34344182-26CA5D08-F5EA-4AEE-B405-7B7BB5E8B481

P407

Q34344182-62E273B0-9E5B-4845-811B-D858E968DE88

P433

Q34344182-5C97D9F3-487B-4494-A2D9-DF9D4D281393

P478

Q34344182-F4B65224-5301-471E-8203-3FF87880F06F

P577

Q34344182-0BF0F2D2-CF59-4B3D-8BC8-96D644D7705F

P5875

Q34344182-2A771C77-7F1D-4A3E-B40D-550420DE2346

P6179

Q34344182-BFFA3A0A-7B23-4E3C-917F-BCB59EEA7CEE

P698

Q34344182-447C29B4-3B52-48FE-86E4-D32B0F89CF20

P921

Q34344182-ABC11F45-C001-4B5F-B384-D4234A709F0B

P932

Q34344182-ECD95603-DAF1-4AC5-A5D2-90AF51913BE9

P356

P1433

British Journal of Cancer

P1476

A phase II study of weekly doc ...... d or metastatic gastric cancer

@en

P2093

C-H Lu

http://www.w3.org/2001/XMLSchema#string

C-J Yen

http://www.w3.org/2001/XMLSchema#string

C-P Li

http://www.w3.org/2001/XMLSchema#string

H-J Tsai

http://www.w3.org/2001/XMLSchema#string

J-S Chen

http://www.w3.org/2001/XMLSchema#string

K-D Lee

http://www.w3.org/2001/XMLSchema#string

L-T Chen

http://www.w3.org/2001/XMLSchema#string

P-C Lin

http://www.w3.org/2001/XMLSchema#string

W-P Su

http://www.w3.org/2001/XMLSchema#string

Y Chao

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.

Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

The role of chemotherapy in the management of gastric cancer.

Capecitabine as adjuvant treatment for stage III colon cancer.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.

New drugs for treatment of gastric cancer.

P2888

P304

1343-1348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605928

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47349829

http://www.w3.org/2001/XMLSchema#string

P6179

1020628590

http://www.w3.org/2001/XMLSchema#string

P698

20924378

http://www.w3.org/2001/XMLSchema#string

P921

P932

2990611

http://www.w3.org/2001/XMLSchema#string